Browsing Tag
heart failure
26 posts
Zydus Lifesciences announces FDA approval for heart failure drug, Ivabradine Tablets
Zydus Lifesciences Limited, a significant player in the pharmaceutical industry, has received final approval from the United States…
December 2, 2023
WhiteSwell’s eLym System shows promise in acute decompensated heart failure treatment
WhiteSwell, a frontrunner in the treatment of acute decompensated heart failure (ADHF), has shared optimistic initial results from…
October 8, 2023
American Regent’s HEART-FID trial for INJECTAFER fails to meet primary endpoint
American Regent, Inc., a subsidiary of Daiichi Sankyo Group, has announced disappointing results from its phase 3 HEART-FID…
August 27, 2023
China’s NMPA expands AstraZeneca’s Forxiga use as heart failure treatment
China’s National Medical Products Administration (NMPA) has approved AstraZeneca’s Forxiga (dapagliflozin) for diminishing the risk of cardiovascular fatalities…
August 20, 2023
Lupin Digital Health unveils Lyfe Digital Heart Failure Clinic
Indian cardiac digital therapeutics entity, Lupin Digital Health (LDH), marked another achievement with the unveiling of its Lyfe…
August 7, 2023
BaroPace gets CDSCO approval for RelieveHFpEF-II clinical trial in India
BaroPace Inc., a medical technology company focused on developing pacemaker regulation techniques based on blood pressure, has been…
July 26, 2023
Viz.ai, Bristol Myers Squibb sign deal for AI algorithm and Viz HCM software
Viz.ai, an artificial intelligence (AI) powered health technology company, has signed a multi-year agreement with Bristol Myers Squibb…
March 4, 2023
Glenmark Pharmaceuticals rolls out heart failure treatment Sacu V in India
Glenmark Pharmaceuticals said that it has rolled out the sacubitril + valsartan tablets for the treatment of heart…
January 17, 2023
Johnson & Johnson to purchase heart pump maker Abiomed for $16.6bn
Johnson & Johnson (J&J) has agreed to acquire Abiomed, a NASDAQ-listed cardiovascular medical technology provider, in an all-cash…
November 2, 2022
Hyloris Pharmaceuticals buys global rights to CRD-102 from Baker Institute
Hyloris Pharmaceuticals has acquired the global rights from Australia-based Baker Heart and Diabetes Institute (Baker Institute) to CRD-102,…
October 8, 2021